OptimizeRx OPRX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $5.13M+126% | -$20.11M-14.5% | -$17.57M-53.6% | -$11.44M-3,125% | ||
| $4.33M-0.1% | $4.33M+80.2% | $2.4M+18.8% | $2.02M— | ||
| $6.96M-39.3% | $11.47M-16.4% | $13.72M-12.9% | $15.75M+187% | ||
| -$1.21M-29.8% | -$935K+83.7% | -$5.74M— | —— | ||
| $1.11M+33.1% | $834K+295% | $211K— | —— | ||
| $0-100% | $208K-68.8% | $666K+83.2% | $363.51K+354% | ||
| —— | $2.17M— | —— | —— | ||
| —— | -$72K+94.5% | -$1.32M-240% | $943.17K+8,343% | ||
| —— | $1.05M-19.2% | $1.3M— | —— | ||
| —— | -$811K— | —— | —— | ||
| —— | $1.03M— | —— | -$1.23M— | ||
| —— | $0— | —— | —— | ||
| —— | —— | —— | $226— | ||
| $18.72M+283% | $4.89M— | —— | $10.65M— | ||
| $58K-48.2% | $112K+28.7% | $87K+7.4% | $81.01K-19.3% | ||
| $68K+115% | -$450K+98.2% | -$25.34M+56.4% | -$58.18M-11,870% | ||
| $8M+100% | $4M+59.0% | $2.52M— | —— | ||
| —— | $911K— | —— | —— | ||
| -$8.8M-79.1% | -$4.91M-117% | $28.22M+249% | -$18.95M-126% | ||
| $9.99M+2,215% | -$472K— | —— | -$66.47M-189% | ||
| $4.18M-32.5% | $6.2M+411% | $1.21M— | —— | ||
| $1.84M+1,043% | $161K+235% | $48K— | —— | ||
| $1.11M+33.1% | $834K+295% | $211K— | —— | ||
| $368K-95.1% | $7.49M— | —— | —— | ||
| —— | $1.05M— | —— | —— | ||
| —— | $0— | —— | —— | ||
| -$1.21M+16.2% | -$1.45M— | —— | —— | ||
| $250K0.0% | $250K— | —— | —— | ||
| —— | —— | —— | $226— | ||
| —— | -$811K— | —— | —— | ||
| —— | —— | $1.52M— | —— | ||
| $0-100% | $208K-68.8% | $666K+83.2% | $363.51K+354% | ||
| —— | $338K-56.9% | $784K+379% | $163.56K-55.1% | ||
| $18.66M+291% | $4.78M— | —— | $10.57M— | ||
| $18.66M+291% | $4.78M— | —— | $10.57M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OptimizeRx generate?
- OptimizeRx (OPRX) generated $14.4M in operating cash flow over the trailing twelve months.
- What is OptimizeRx's free cash flow?
- After $52.0K of capital expenditures, OptimizeRx's free cash flow was $14.3M over the trailing twelve months, up 119.5% year over year.
- Where does OptimizeRx's cash flow data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
